How would you manage axial spondyloarthritis in a patient who was doing well on TNF inhibitor therapy then developed a new solid organ malignancy while on treatment?
How does the management differ if the cancer is resectable or requires systemic treatment?
Community PollStarted
How would you manage TNFi therapy in a patient with axial spondyloarthritis who develops solid organ malignancy while on TNFi?
127 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Rheumatology · Stanford University
Answered on
The story here is an important one. I was able to discuss this with @Dr. First Last, who supplied important insights. Most of the good (and bad) data supporting what to do when your patient had a prior malignancy in remission or who develops one on treatment comes from experience with treating rheum...
Join for free or sign in to see the full answer